C5M4D4 AF NFT

Phosphatidylethanolamine N-methyltransferase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeiaepcggfitjgcfudfqkhupyxrt5t7dg7ail36rlmr2nv6fxm5yahm/metadata.json
IPFS of structure file: 
bafybeic5ixrun533rwnhcek4h4yei7vg7ioukhnttfyjgvouary45hxh4e/AF-C5M4D4-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x017919F1bE1124b92211d6Ce23B1B47B990387b9
First NFT owner address (bech32): 
genesis1q9u3nud7zyjtjgs36m8z8vd50wvs8pae4e6ady
Current NFT ID #62508 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
62508
Accession (UniProt):
C5M4D4
Name::
Phosphatidylethanolamine N-methyltransferase
Experimental Method:
Predicted structure
Sequence source:
Candida tropicalis (strain ATCC MYA-3404 / T1)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT C5M4D4 research and analysis (ICN3D with VR)

FASTA sequences

>sp|C5M4D4|CHO2_CANTT Phosphatidylethanolamine N-methyltransferase OS=Candida tropicalis (strain ATCC MYA-3404 / T1) OX=294747 GN=CHO2 PE=3 SV=1 MPSLTQTRSTVSELNTSAIETSTMSDSGHQNKPKGPKGITFSGETFIVPETHDMVKTLFDPTIKKSNFELIILGLLFSNLLVFLIPNNNLRISIFIGFYIFWRLSYNFGIGWLLQHQSNDHLLVQWAIKYKLFDKNNKNFLAKLVQSEIKSQRGDAYDINSYPIEFNTWLIFRKFVDLILMSDFTTFICVVYACSINNDYQFIKNQPSWLTMSRIVGGSILILFNYWVKVNAHNTIKDYAWYWGDFFFRQINNEELIFDGVFEMFPHPMYSVGYVGYYGFALISKSYIVLLTAIFGHFLQMIFLHYIENPHIDKIYGPSKNEINLIKILKLKDLKNFDNLKPLVGLYNFNWMRASDVINLVLSLTYGLIIPVFAKSLKSLFVLTVATKLFESLSINILLILQSQFKFFTKWSLSNDIPIEKSLNNWAVLYNSLINLTYSSLFGLNLGYFLQGTGSSLVTDYFYLRLFLGLCLIYTQSWINLSIIDSIGYFGWFYGDFFIPKSQSSIKNLTQAGVYRYLNNPEQIFGVCGVMGVFLIHPTVENLTCCILWMVNNFVRINFIEKIHMIRIYGEKEVNRDSGVTKTVKKHLIPDVIQRKMSNDDPKRRGGVANGTSLGDSLDNFIKELRNSTTKLSQQKLIELSQNLSFANSNYKLSIDGLKESNELKYTTIGTPITVSWQSPSNTHSIRDWVGLYKIVQTSYSRNKTILSSAGRWTYCTDSKGVFTFEKEKLFWEEGVYEFRYHLDGKHDVAYISEPFEIKSVDIDVPGDISEAGEFSKQLKTEIFDKIIDIKSINESIAPIANQADNVIEVYKLFSSLISKSTQINVNYRIFLNNDNLSISDVAHKLIDIKQVLQELSFNSSEKKNL